330 related articles for article (PubMed ID: 31399022)
21. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia.
Huang X; Li D; Liu F; Zhao D; Zhu Y; Tang H
BMC Infect Dis; 2021 Jan; 21(1):14. PubMed ID: 33407216
[TBL] [Abstract][Full Text] [Related]
22. Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice.
Yoshikawa E; Tamiya S; Inoue Y; Suzuki K; Yoshioka Y
Biochem Biophys Res Commun; 2022 Feb; 594():81-87. PubMed ID: 35078111
[TBL] [Abstract][Full Text] [Related]
23. Highly homogeneous microbial communities dominated by
Chen J; Xi Z; Shi Y; Liu L; Wang L; Qian L; Lu A
Transl Pediatr; 2021 Mar; 10(3):604-615. PubMed ID: 33850819
[TBL] [Abstract][Full Text] [Related]
24. [Levels of interleukin-4 and interferon-gamma in the bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia].
Huang H; Zhong LL; Peng L; Li J; Lin L
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):581-4. PubMed ID: 22898277
[TBL] [Abstract][Full Text] [Related]
25. [Levels of TNF-α, IL-6 and IL-10 in bronchoalveolar lavage fluid in children with Mycoplasma pneumoniae pneumonia].
Pang HX; Qiao HM; Cheng HJ; Zhang YF; Liu XJ; Li JZ
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Oct; 13(10):808-10. PubMed ID: 22000436
[TBL] [Abstract][Full Text] [Related]
26. Altered chemokine profile in Refractory Mycoplasma pneumoniae pneumonia infected children.
Lee YC; Chang CH; Lee WJ; Liu TY; Tsai CM; Tsai TA; Tsai CK; Kuo KC; Chen CC; Niu CK; Yu HR
J Microbiol Immunol Infect; 2021 Aug; 54(4):673-679. PubMed ID: 32299786
[TBL] [Abstract][Full Text] [Related]
27. The CARDS toxin of
Wang T; Sun H; Lu Z; Jiang W; Dai G; Huang L; Wang M; Zhu C; Wang Y; Hao C; Yan Y; Chen Z
Front Immunol; 2022; 13():1054788. PubMed ID: 36532054
[TBL] [Abstract][Full Text] [Related]
28. Analysis of cytokine levels, cytological findings, and MP-DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia.
Deng F; Cao H; Liang X; Li Q; Yang Y; Zhao Z; Tan J; Fu G; Shu C
Immun Inflamm Dis; 2023 May; 11(5):e849. PubMed ID: 37249293
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children].
Xu JJ; Shu LH
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jan; 20(1):37-42. PubMed ID: 29335080
[TBL] [Abstract][Full Text] [Related]
30. [Early identification of refractory Mycoplasma pneumoniae pneumonia in children].
Wang Z; Li YC; Chen L
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1189-92. PubMed ID: 26575876
[TBL] [Abstract][Full Text] [Related]
31. Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model.
Li M; Wei X; Zhang SS; Li S; Chen SH; Shi SJ; Zhou SH; Sun DQ; Zhao QY; Xu Y
BMC Pulm Med; 2023 Oct; 23(1):383. PubMed ID: 37817172
[TBL] [Abstract][Full Text] [Related]
32. iTRAQ-based Quantitative Proteomics Study in Patients with Refractory Mycoplasma pneumoniae Pneumonia.
Yu JL; Song QF; Xie ZW; Jiang WH; Chen JH; Fan HF; Xie YP; Lu G
Jpn J Infect Dis; 2017 Sep; 70(5):571-578. PubMed ID: 28003598
[TBL] [Abstract][Full Text] [Related]
33. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.
Li P; Wang W; Zhang X; Pan J; Gong L
Sci Rep; 2024 Mar; 14(1):5632. PubMed ID: 38453960
[TBL] [Abstract][Full Text] [Related]
34. The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children.
Zhang Y; Zhou Y; Li S; Yang D; Wu X; Chen Z
PLoS One; 2016; 11(5):e0156465. PubMed ID: 27227519
[TBL] [Abstract][Full Text] [Related]
35. The role of miR-29c/B7-H3/Th17 axis in children with Mycoplasma pneumoniae pneumonia.
Li QL; Wu YY; Sun HM; Gu WJ; Zhang XX; Wang MJ; Yan YD; Hao CL; Ji W; Chen ZR
Ital J Pediatr; 2019 May; 45(1):61. PubMed ID: 31088519
[TBL] [Abstract][Full Text] [Related]
36.
Ramasamy K; Balasubramanian S; Manickam K; Pandranki L; Taylor AB; Hart PJ; Baseman JB; Kannan TR
mBio; 2018 Jan; 9(1):. PubMed ID: 29362229
[No Abstract] [Full Text] [Related]
37. The predictive values of soluble B7-DC in children with refractory mycoplasma pneumoniae pneumonia.
Zhang WH; Zhou MP; Zou YY; Chen JW; Wang T; Huang L; Yan YD; Ji W; Zhu CH; Chen ZR
Transl Pediatr; 2023 Mar; 12(3):396-404. PubMed ID: 37035403
[TBL] [Abstract][Full Text] [Related]
38. [A multicenter prospective study on early identification of refractory
Xu D; Zhang AL; Zheng JS; Ye MW; Li F; Qian GC; Shi HB; Jin XH; Huang LP; Mei JG; Mei GH; Xu Z; Fu H; Lin JJ; Ye HZ; Zheng Y; Hua LL; Yang M; Tong JM; Chen LL; Zhang YY; Yang DH; Zhou YL; Li HW; Lan YL; Xu YL; Feng JY; Chen X; Gong M; Chen ZM; Wang YS
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):317-322. PubMed ID: 38527501
[No Abstract] [Full Text] [Related]
39. Atopy: a risk factor of refractory mycoplasma pneumoniae pneumonia?
Bao YX; Li J; Tian Y; Liu QH; Bao J
Clin Respir J; 2017 Nov; 11(6):931-934. PubMed ID: 26683420
[TBL] [Abstract][Full Text] [Related]
40. Clinical Role of Serum Interleukin-17A in the Prediction of Refractory
Zhao J; Ji X; Wang Y; Wang X
Infect Drug Resist; 2020; 13():835-843. PubMed ID: 32210598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
